Quest Diagnostics Declares Quarterly Cash Dividend
Get Alerts DGX Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 1.8%
EPS Growth %: +7.6%
Join SI Premium – FREE
SECAUCUS, N.J., Nov. 20, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.53 per share, payable on January 29, 2020 to shareholders of record of Quest Diagnostics common stock on January 14, 2020.

About Quest DiagnosticsQuest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 46,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. www.QuestDiagnostics.com.
View original content to download multimedia:http://www.prnewswire.com/news-releases/quest-diagnostics-declares-quarterly-cash-dividend-300961551.html
SOURCE Quest Diagnostics
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sunshine Silver Mining & Refining Announces Pricing of Initial Public Offering
- FGR accelerates USA expansion & defence sector exposure with strategic acquisition of MITO® Material Solutions
- Colombian Pharmaceutical Distributor Cuts Drugstore Procurement Costs by 50% Using Its Own In-House AI Engine – Now Serving 6,000+ Pharmacies Across Latin America
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share